What is the appropriate 125 mL D10W (10% dextrose in water) bolus for a 137‑lb (≈62 kg) adult with hypoglycemia?

D10W 125 mL Bolus for Hypoglycemia in a 137-lb Adult

For a 137-lb (62 kg) adult with hypoglycemia, a 125 mL bolus of D10W (delivering 12.5 g of dextrose) is appropriate and aligns with current evidence-based recommendations for titrated dextrose administration.

Recommended Approach

The most recent high-quality guideline evidence from Critical Care Medicine 1 specifically advocates for titrated 10% dextrose in 50-mL (5-g) aliquots rather than traditional large-dose approaches. This strategy:

• Corrects blood glucose into target range in 98% of patients within 30 minutes
• Avoids overcorrection and rebound hyperglycemia
• Reduces total dextrose dose required (median 10 g vs. 25 g with D50)
• Results in more physiologic post-treatment glucose levels (112 mg/dL vs. 169 mg/dL)

Your 125 mL D10W bolus delivers 12.5 g of dextrose, which falls within the recommended 10-20 g range 1. This is more than the initial 5-g aliquot but less than the traditional 25-g dose, representing a reasonable middle-ground approach.

Clinical Algorithm

Step 1: Initial Assessment

• Confirm hypoglycemia (blood glucose ≤70 mg/dL with symptoms)
• Assess mental status and ability to take oral intake
• Ensure IV access is secure

Step 2: Initial Treatment

• Administer 125 mL D10W IV over 1-2 minutes (12.5 g dextrose)
• Alternatively, give 50 mL D10W (5 g) and repeat every minute as needed 1

Step 3: Monitoring

• Recheck blood glucose in 10-15 minutes
• Assess symptom resolution and mental status

Step 4: Additional Dosing if Needed

• If glucose remains <70 mg/dL or symptoms persist: give additional 50 mL D10W (5 g)
• Repeat glucose checks every 10-15 minutes until stable
• Maximum total dose typically 20-25 g

Step 5: Maintenance

• Once glucose normalized, provide oral intake if patient able
• Consider continuous D10W infusion if recurrent hypoglycemia risk (e.g., sulfonylurea overdose)

Evidence Supporting D10W Over D50W

Multiple studies demonstrate D10W superiority:

Prehospital data 2 showed D10W in 5-g aliquots achieved:

• Similar time to recovery (8 minutes for both concentrations)
• Significantly lower total dose required (10 g vs. 25 g; p<0.001)
• Lower post-treatment glucose (6.2 mmol/L vs. 9.4 mmol/L; p=0.003)
• No extravasation injuries in either group

Recent RCT evidence 3 confirmed no difference in time to achieve GCS 15 between D10, D25, and D50 (all 6 minutes), but:

• D10 and D25 required lower median total doses (10 g vs. 15 g)
• Fewer patients in D10/D25 groups received maximum 25 g dose (3-4% vs. 12%)

Large observational cohort 4 of 1,323 patients treated with 100 mL D10 showed:

• 87.5% successfully treated with initial 100 mL dose
• Only 23% required second dose
• 0.8% required third dose
• Zero adverse events or deaths
• Median post-treatment glucose 91 mg/dL (appropriate range)

Critical Pitfalls to Avoid

1. Overcorrection with D50W

• Traditional D50W (25 g bolus) frequently causes excessive hyperglycemia (>150 mg/dL)
• Post-hypoglycemic hyperglycemia may contribute to neuronal injury 5
• Rapid administration of concentrated dextrose associated with cardiac arrest and hyperkalemia 1

2. Extravasation Risk

• D50W is highly irritating to veins and causes tissue necrosis if extravasated
• D10W significantly safer for peripheral IV administration 2

3. Inadequate Monitoring

• Hypoglycemia may recur, especially with sulfonylurea overdose or insulin excess
• Recheck glucose every 15-30 minutes initially, then hourly until stable
• Provide oral intake or continuous dextrose infusion to prevent recurrence

4. Delayed Treatment

• In altered mental status, do NOT attempt oral treatment first
• IV dextrose preferred over glucagon due to faster onset (minutes vs. 140 minutes) 1

Special Considerations

For insulin-induced hypoglycemia in ICU patients: The formula (50% dextrose dose in grams = [100 − BG] × 0.2 g) typically recommends 10-20 g IV dextrose 1, making your 12.5 g dose appropriate.

For sulfonylurea overdose: Prolonged observation and repeated dosing may be necessary. Consider octreotide as adjunct 5. Hospitalization often required.

If D10W unavailable: D25W or D50W can be used but require more careful titration. D50W should be diluted when possible and given slowly to minimize complications 6.

Bottom Line

A 125 mL D10W bolus (12.5 g dextrose) is an evidence-based, safe, and effective treatment for hypoglycemia in your 137-lb adult patient 1, 3, 4, 2. This approach balances rapid glucose correction with avoidance of rebound hyperglycemia, requires less total dextrose than traditional protocols, and carries minimal risk of extravasation injury. Monitor response at 10-15 minutes and be prepared to give additional 50 mL aliquots if needed.